
What We’re Reading: GSK Partners With CureVac; Oxford Updates Efficacy Results; Pharmacies to Receive Vaccine
GlaxoSmithKline (GSK) and CureVac will partner to accelerate coronavirus disease 2019 (COVID-19) vaccine production; new data show 76% efficacy for Oxford’s COVID-19 vaccine; 1 million vaccine doses will be sent to 6500 pharmacies.
GSK, CureVac to Produce COVID-19 Vaccines
GlaxoSmithKline (GSK) has announced that German biotech firm CureVac will help to both produce 100 million additional doses of its current coronavirus disease 2019 (
Oxford, AstraZeneca Announce Updated Data
Interim study results of ChAdOx1 nCoV-10 (AZD1222),
Nationwide Pharmacies to Receive Vaccine Doses
By next week, nationwide pharmacies that include CVS, Walgreens, Walmart, Costco, and several supermarket chains could receive 1 million doses of available COVID-19 vaccines,
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.